G6PD and rheumatoid arthritis: Peripheral and tissue resident T-cells from people with RA have a unique metabolic signature with an impairment of glycolysis due to a deficiency of PFKFB3, resulting in delayed glycolysis and increased PPP via the up-regulation of glucose-6-phosphate dehydrogenase (G6PD) [3].